Organic Process Research & Development
COMMUNICATION
thickness). Carrier gas/flow: helium/2.0 mL/min. Inlet tem-
perature: 200 °C; split ratio 20:1. Detector temperature: 300 °C;
H2 flow = 30 mL/min; air flow = 300 mL/min; makeup gas =
helium (30 mL/min). Injection volume: 2 μL. Gradient: 100-
300 at 10 °C/min.
(15) (350 mg, 1.11 mmol), trimethyl(phenylethynyl)silane
(338 mg, 1.94 mmol), triphenylphosphine (58.1 mg, 0.221
mmol), copper(I) iodide (5.16 mg, 0.058 mmol), potassium
carbonate(765mg, 5.54mmol), bis(triphenylphosphine)palladium-
(II) chloride (40.4 mg, 0.058 mmol), NMP (1.0 mL) and metha-
nol (0.75 mL) were heated to 77 °C. The mixture was stirred
overnight at this temperature. The mixture was cooled to room
temperature, passed through a Celite bed, and added to ice. The
solids were filtered, and the desired product was recrystal-
lized from 10% ethyl acetate and 90% hexanes. The solids were
filtered and dried under vacuum at 60 °C overnight to give 1-(4-
fluorophenyl)-2,5-dimethyl-4-phenylethynyl-1H-imidazole (6a)
Flow NMR. Spectra were acquired on a Varian VNMRS
1
400 MHz spectrometer operating at a H frequency of 399.75
MHz. The probe was a Varian inverse detect 3 mm/60 μL triple
resonance (HCN) probe equipped with single-axis pulsed field
gradients. Solvent suppression was achieved using the WET
pulse sequence, and all data were acquired with no deuterium
lock. The reaction mixture was transferred from the reaction flask
to the flow probe and back in a single loop via a Hewlett-Packard
series 1050 HPLC pump operating at a flow rate of 1.0 mL/min.
An acquisition time of 2.318 s with a relaxation delay of 0.682 s
was used, and eight scans were acquired for each spectrum.
N0-(4-Fluorophenyl)-N,N-dimethylacetamidine (18). 4-
Fluoroaniline (24.12 g, 0.217 mmol) and (46.33 g, 347 mmol) of
N,N-dimethylacetamide dimethylacetal were heated to 85 °C
while stirring and were kept at this temperature overnight. The
mixture was cooled to room temperature to give the desired
product in 99% purity (a/a GC). MS m/z 180 [M]þ. The
mixture was used as is.
1
as a tan solid (230 mg, 72%). MS m/z 291 [M]þ. H NMR
(500 MHz, DMSOd6) δ 7.54-7.37 (m, 9H), 2.12 (s, 3H),
2.09 (s, 3H).
1-(4-Fluorophenyl)-2,5-dimethyl-4-o-tolylethynyl-1H-
imidazole (6b). Compound 6b was synthesized using the pro-
cedure described above for 6a. 1-(4-Fluorophenyl)-2,5-dimeth-
yl-4-o-tolylethynyl-1H-imidazole (6b) was isolated as a tan solid
1
(141 mg, 75%). MS m/z 305 [M]þ. H NMR (500 MHz,
DMSOd6) δ 7.56-7.38 (m, 5H), 7.25 (dddd J = 26.8, 15.3,
7.3 Hz, 3H), 2.43 (s, 3H), 2.11 (3H), 2.09 (s, 3H).
Flow NMR Experiment. N0-(4-Fluorophenyl)-N,N-dimethy-
lacetamidine (18) (1.0 g, 5.2 mmol) and propargylamine (12)
(0.409 g, 7.4 mmol) were added to acetonitrile (30 mL) at 0 °C.
Glacial acetic acid (1.0 g, 16.6 mmol) was then added to the
mixture over 2 min. After 10 min, the reaction was heated to 80 °C
and stirred for 3 h. Note: these solvents were not deuterated.
1-(4-Fluorophenyl)-2,5-dimethyl-1H-imidazole (14). N0-(4-
Fluorophenyl)-N,N-dimethylacetamidine (18) (101 g, 560 mmol)
was cooled to 0 °C and 36.5-38% hydrochloric acid (61.3 g,
1.68 mol) was added over 40 min. Propargylamine (12) (37.0 g,
673 mmol) was added to the mixture and the mixture was stirred
for 15 min. The reaction temperature was increased to 85 °C and
kept at this temperature for 5 h. The mixture was cooled to 25 °C
and MTBE (404 mL) and an aqueous solution of saturated sodium
bicarbonate (202 mL) were charged while stirring. The phases
were separated, and the aqueous phase was washed with MTBE
(404 mL). The combined organic phases were washed with water
(202 mL). The organic phase was separated, and the solvent was
distilled off to give 14 as an oil in 94% purity (a/a GC). MS m/z
190 [M]þ. 1H NMR (400 MHz, DMSOd6) δ 7.58-7.26 (m, 4H),
6.65 (s, 1H), 2.10 (s, 3H), 1.96 (s, 3H). The product was used as is
in the next step.
’ ASSOCIATED CONTENT
S
Supporting Information. Data obtained from the DOE
b
study. ARC data for compounds 2, 4 ,and 14 as well as 1H NMR
and IR spectra, GC and MS analyses for key intermediates 18, 14,
15, 6a, 6b. This material is available free of charge via the Internet
’ AUTHOR INFORMATION
Corresponding Author
*ana.barrios_sosa@roche.com Telephone: 843-629-4000. Fax:
(843)-629-4128.
’ ACKNOWLEDGMENT
We thank Paul Spurr and Dr. Pingsheng Zhang for their
helpful comments. We also thank Dieu Nguyen for her assistance
in the translation of relevant articles and Stephen Chan, Crystal
Fields, and Jim Suchy for their assistance with MS and IR data.
’ REFERENCES
(1) (a) Buettelmann B.; Ceccarelli S.; Jaeschke G.; Kolczewski S.;
Porter R.; Spurr P.; Vieira E. Imidazole Derivatives. U.S. Pat. Appl. U.S.
20050054686, 2005; CAN 142:298113 (b) Buettelmann B.; Ceccarelli
S.; Jaeschke G.; Kolczewski S.; Porter R.; Spurr P.; Vieira E. Preparation
of pyridin-4-ylethynylimidazoles and -pyrazoles as mGluR5a receptor
antagonists. PCT Int. Appl. WO/2005118568, 2005; CAN 144:51579
(c) Buettelmann, B.; Ceccarelli, S.; Jaeschke, G.; Kolczewski, S.; Porter,
R.; Vieira, E. Preparation of (1H-imidazol-4-yl)ethynylpyridines as
metabotropic glutamate 5 receptor antagonists for treating neurodegen-
erative diseases, in particular anxiety. PCT Int. Appl. WO/2004080998,
2004; CAN 141:296020 (d) Buettelmann, B.; Ceccarelli, S.; Jaeschke,
G.; Kolczewski, S.; Porter R.; Vieira, E. A preparation of (pyridin-4-
ylethynyl)imidazole derivatives, useful for the treatment of mGluR5
receptor mediated disorders. U.S. Pat. Appl. U.S. 2004248888, 2004;
CAN 142:23285 (e) Buettelmann, B.; Ceccarelli, S.; Jaeschke, G.;
Kolczewski, S.; Philip, P.; Vieira, E.; Ford, A.; Zhong, Y. A preparation
of (pyridin-4-ylethynyl)imidazole derivatives, useful for the treatment of
mGluR5 receptor mediated disorders. U.S. Pat. Appl. U.S. 2005143375,
2005; CAN 173:78185
1-(4-Fluorophenyl)-4-iodo-2,5-dimethyl-1H-imidazole
(15). Sodium periodate (3.67 g, 17.1 mmol), 1-(4-fluoro-
phenyl)-2,5-dimethyl-1H-imidazole (14) (9.99 g, 52.6 mmol),
2.4 M sulfuric acid (17.5 mL, 42.1 mmol) and methanol (l00 mL)
were heated to 60 °C. A solution of iodine (9.43 g, 37.2 mmol)
in methanol (100 mL) was added over 1 h. The mixture was
stirred for 4 h at this temperature. The mixture was cooled to
20 °C, and a solution of sodium bisulfite (0.175 g, 1.68 mmol) in
water (50 mL) was added. The pH of the mixture was adjusted to
pH = 14 with 42% sodium hydroxide. The solids were filtered
and washed with water (20 mL). The solids were dried under
vacuum at 60 °C overnight to give 1-(4-fluorophenyl)-4-iodo-
2,5-dimethyl-1H-imidazole (15) (11.1 g, 67%) as a brown solid.
1
MS m/z 316 [M]þ. H NMR (400 MHz, DMSOd6) δ 7.54-
7.30 (m, 4H), 2.06 (s, 3H), 1.91 (s, 3H).
1-(4-Fluorophenyl)-2,5-dimethyl-4-phenylethynyl-1H-imida-
zole (6a). 1-(4-Fluorophenyl)-4-iodo-2,5-dimethyl-1H-imidazole
453
dx.doi.org/10.1021/op100335q |Org. Process Res. Dev. 2011, 15, 449–454